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ABSTRACT: Modern oncology is a rapidly growing area in medicine.  Cancer is a disease 
diagnosed on the basis of cellular changes hence objectivity takes the lead.  Clinical observation, 
detailed examination and some feasibility studies were conducted in Ayurvedic methods to 
understand and identify cancer systematically.  Abdominal presentation as tumour is discussed 
since it is one of the major area for clinical diagnosis of cancer.  More than 100 cases were 
followed in each type at all stages to understand the natural history and clinical behaviour.  
After careful study, the Ayurvedic diagnosis with possible aetiologic association has been 
arrived at and discussed.  Three main classification has been made and presented separately.  
Visha concept of Ayurveda has been very closely found to be associated in malignancy. 
 
INTRODUCTION 
 
Ayurveda – age old Indian art of health and 
medicine, and cancer –  a disease about 
which the medical science has developed 
considerable experience only recently, are 
meeting each other at a time when medicine 
is in its frontiers.  Just as the cancer cell 
biology has contributed to development of 
basic biologic understandings, the clinical 
study of cancer by an Ayurvedic physician 
leads to immense introspection in to the 
entire knowledge base built on textual basis.  
The experience is unique in many aspects 
and thus has opened a new dimension which 
needs  to be examined in detail leading to 
proper understanding of the disease.  In the 
absence of any previous experience and lack 
of guidance and also because of paucity of 
literature,  it was  like  endeavoring  a new 
venture.  Following the advice of Charaka 
(1) promptly, the patients were studied with 
respect to their clinical parameters and 
detailed analysis was carried out with the 
help of texts.  This paper presents the 
current concepts formulated with pragmatic 
approach within the frame work of 
Ayurveda. 
 
OBJECTIVES AND METHODS 
 
The main objectives is to identify the 
disease known by the name of “cancer” – 
according to Ayurveda  and understand the 
aetiopathogenesis in the frame of Dosha-
Dhatu-Mala triod leading to establishements 
of Samprathi – eventually evolving the line 
of treatment.  Working in one of the leading 
cancer hospital set up in India, provided an 
excellent opportunity to study, hence 
initially all types of patients were observed 
at various stages by regular follow up at out 
patients as well as in patient.  It was realized 
that each type of cancer needs more 
attention.  Hence, only a few types were 
selected for detailed examination.  With the 
help  of a well maintained cancer registry 
from where the data was taken and in Pages 218 - 231 
addition, more specific data required from 
Ayurvedic  point of view was obtained 
prospectively.  Review of literature, both 
ancient Ayurvedic  texts and modern medical 
texts and Journals was done along with the 
clinical study.  Discussions were held with 
concerned physicians on individual cases.   
An experimental account of six years of 
exercise, the conclusions were drawn 
utilizing the collected data. 
 
CURRENT CONCEPTS OF CANCER 
 
Cancer is not a single disease as generally 
believed.  It has a very wide spectrum of 
conditions but have some commonness.  It is 
now well understood that cancer is the result 
of cellular genetic changes leading to 
abnormal proliferation of such ‘altered’ cells 
which grow disproportionate to the needs of 
the body and pervades all vital parts if not 
controlled effectively.  Hence its diagnosis 
is an elaborate but a precise process done by 
a biopsy of the affected tissue. Clinical 
examination is of course mandatory 
although not conclusive.  The words like 
“neoplasm”, “malignancy”, “oncogenesis”, 
“carcinogenesis”, “cancer”, etc are 
essentially attributed to such genetically 
determined tumour related clinical 
conditions.  Hence cytogenetic examination 
is emerging as a new dependable technique.  
Although, clinically cancer manifests in 
wide spectrum of signs and symptoms, they 
are characterized by the involvement of 
definite tissue which can be identified 
microscopically depending on the cell of 
origin.  The natural history and biology 
progresses into a definite clinical pattern.   
The tumour cells are monoclonal  (arising 
from single cell) which secret certain 
substances, which are used as tumour 
markers by biochemical methods.  Tumor 
cells migrate through lymphatic or 
haematological channels to other areas of 
the body and develop into tumours.  They 
can even spread directly to neighbouring 
tissues with their immense speed of growth 
at the cost of the host and endagers its 
existence.  Number of aetiological factors 
have been identified such as radiation, 
chemicals, drugs, viruses etc.  The host 
factors itself contributes in the pathology.   
However, enormous amount of work is still 
in progress in different countries of the 
world.  This has assumed a separate branch 
of medical science known as Oncology. 
 
CANCER AND AYURVEDA 
 
Nature’s phenomenon has been the same, 
but man understands it in his own way at 
different points of time.  In the history of 
medicine we have seen this clearly.  Cancer 
can be stated to be the child of scientific 
medicine’s technological innovation.  The 
microscope that revolutionized the medicine 
with bacterioviral causation, also did 
similarly in the cellular basis concept of 
cancer aetiology.  Obviously it is very 
recently understood phenomenon.  The 
objective evaluation of any theory is the 
Darshanic concept of Pratyaksha.  Ayurveda 
and contrarily, modern medicine depends on 
objectivity, hence to understand cancer in 
the language of  Ayurveda is like adding a 
new chapter to Nidana Sthana of Charaka 
samhita.  The need for such a work needs to 
be emphasized.  All that we have is a few 
samhitas and they are the only source of 
information.  This work attempts to analyse 
(Anumana)  on the basis of clinical study 
(Pratyaksha)  correlating with the shastra 
(Aagama or Aaptopadesha).  This confirms 
to the code of Ayurvedic  tradition.  No 
shastra can develop unless it keeps pace 
with related systems.  Sushruta’s  advise has 
been well taken. 
 
Cancer patients presenting as mass in the 
abdomen is one of the major area as quite 
number of cancers have this clinical Pages 218 - 231 
condition commonly.  Over the period of six 
years, a study of all cancers which are 
known to be associated with mass in the 
abdomen were taken up to understand the 
natural history and clinical behaviour during 
stages of the disease.  Modern oncology has 
systematically established on the basis of the 
cell involved in different cancers in most of 
the varieties.  The study convincingly 
proved that the various classifications found 
in oncology is fully justified as their cell of 
origin, tumour developing speed, clinical 
behaviour, signs and symptoms, type of 
metastisi are well understood and 
demonstratable.  Since these are absolutely 
objective and non-ambiguous the diagnosis 
established was taken as the base for study. 
 
TABLE 1 
 
MALIGNANT TUMOURS WHICH 
PRESENT CLINICALLY AS MASS IN 
THE ABDOMEN. 
 
1.  PRIMARY CANCERS OF THE 
ABDOMINALREGION (ADULTS): 
 
Carcinomas of stomach 
Pancreas 
Colon 
Kidney 
Ovary 
Endometrium 
Bladder 
Non-Hodgkins lymphoma 
Hodgkins disease 
Hepatocellular carcinoma 
Chronic myeloid leukemia 
Acute lymphocytic leukemia 
Chloroma in Acute myeloid leukemia 
Retroperitoneal sarcomas 
 
2.  METASTIC CANCERS (PRIMARY 
KNOWN OR UNKNOWN) IN 
ADULTS: 
 
Female breast cancers with abdominal 
lymphnodes metastasis 
Oesophagus cancer with extension to 
stomach 
Lung cancer with lymph node metastas. 
Testicular cancers with lymphnode 
metastasis 
Malignant melanoma with abdominal 
metastasis 
Metastasis to ovary by breast and stomach 
cancers 
Metastasis to omentum or to peritonlum by 
stomach, colon and ovary cancers. 
Metastasis to liver by breast, oesophagus, 
stomach, pancreas, melanoma, colon, 
Ewing’s sarcoma, Renal tumours. 
 
3.  PAEDIATRIC MALIGNACIES: 
 
Acute leukemia 
Lymphoma (Non-Hodgkin’s and Hodgkin’s) 
Neuroblastoma 
Wilm’s tumour or nephroblastoma 
Hepatoblastoma 
Rhabdomyo sarcoma 
Germ cell tumour 
Chronic myeloid leukaemia 
Metastasis to liver from other primary sites Pages 218 - 231 
Lymphnode metastasis from other primary 
sites. 
 
DISCUSSION AND ANALYSIS 
 
I.  (A) Abdominal tumours 
 
An Ayurvedic physician can think of Gulma 
or Udara clinically and uses all his efforts to 
make a diagnosis.  He may finally classify 
under doshic category, but the precise 
details, exact location, relation to other 
organs and finally the stage cannot be 
clinically appreciated.  Now the question of 
this tumour being “cancer” or not is a non 
entity in the absence of present oncology 
knowledge.  The doshic classification itself 
will be disputable as it has a strong and 
inevitable subjective bias. 
 
DISCUSSION 
 
Gulma is one most important disease found 
in Ayurvedic literature to describe tumoursof 
the abdomen.  Charaka infact has dealt only 
six disease of physical origin in Nidana 
sthana  in which gulma  represents the 
abdominal disorders with mass but Sushruta 
has taken under Udara.  Experiences in this 
study clearly showed that both these are to 
be taken to understand abdominal malignant 
tumours in Ayurvedic context. 
 
Although  gulma  is the most probable 
diagnosis clinically, all mass abdomen cases 
cannot be included as evident from the 
Table 1.  Another condition Abyantara 
Vidradhi was also taken up for recognizing 
the malignant condition, as it appeared close 
to  gulma.  Granthi is the proper term to 
describe tumour.  Arbuda is also a granthi, 
but both these have not been described as 
abdominal tumours at all.  But, both 
Charaka  and  Sushruta  have mentioned 
gulma as a granthi originating in the gastro 
intestinal tract.  It is a hard mass confined to 
the five anatomical positions.  However, all 
the  gulmas  do not appear to be malignant 
type.  The Tridoshaja  or  Nichaya gulma 
having stone hard elevated mass which is 
described as incurable must be a malignant 
tumour.  The locations of gulma  covers 
almost the entire abdomen region from 
diaphragam to inguinal region and hence 
any of the tumour in the table 1 can be 
gulma.  But as per Sushruta gulmas doesn’t 
involve dhatus but only doshas and hence 
obviously the mass doesn’t originate from a 
tissue.  From this description and also due to 
exclusion of gulma    from surgical 
management it is not possible to draw 
conclusion about gulma’s  malignant 
identity.  Among the udara rogas 
yakritodara  and  pleehodara  are to be 
excluded here as they have been identified 
without ambiguity (dealt separately in the 
end).  Gulma like mass are said to occur in 
udaras and have progressively frieghtining 
course.  Since all udaras  are generally 
regarded as maharogas  indicating extreme 
difficult clinical situation, and udaras  are 
terminal events of chronic pathological 
process, it is felt necessary to regard some of 
them as malignant.  Most of the explanations 
in the texts appear clearly on the basis of 
external examination and definitely not by 
exploratory laparotomy. 
 
The  Sannipatodara  which is specially 
mentioned by Sushruta as Dooshyodara 
needs to be given special attention.  It is 
unique in many ways.  The etiology relating 
to dooshivisha and garavisha and producing 
typical serious signs and symptoms makes it 
appear malignant.  The modern aetiology of 
all cancers referring to radiation, chemicals, 
drugs, viruses are all vishas in the Ayurvedic 
terminology.  All the primary cancers of the 
abdomen and metastic cancers with primary 
else where ultimately produce udara and 
most of them also progresses to jalodara Pages 218 - 231 
also.  When we examine the environment in 
which we are living and food and other 
substances to which we are exposed to, we 
can imagine the extent of our exposure to so 
many toxic substances.  Since most of them 
are scientifically known as toxic, these 
chemicals and drugs have to be taken as 
dooshi or gana vishas.  Hence in this study 
dooshyodara  emerged as the important 
disease to identify and correlate with the 
malignant abdominal tumours.  Further, the 
viruddahara  and  vishamahara  are well 
known to produce gara like situation which 
appeared very relevant from the 
observations made in the study.  The term 
mahodara yakritpleehee  in gara is note 
worthy. 
 
The non-hodgkins lymphoma in both 
children and adults, advanced abdominal 
hodgkins disease, ovarian cancer, peritoneal 
and omentum metastasis of various other 
tumours typically, progresses and presents 
like dooshyodara. 
 
125 paediatric and 180 cases of adult NIIL 
were studied out of which 137 cases were 
abdominal and other cases were either 
mediastinal are peripheral nodal and extra 
nodal.  Non abdominal NHL also progresses 
finally reach abdomen.  Hence all cases 
were studied.  Table 2 shows the important 
signs and symptoms. 
 
As explained by Sushrutai and Charaka the 
visha or toxic aetiology is now scientifically 
well established.  All visha dravyas  have 
great potential to bypass the doshas in the 
body and spread along all routes and vitiate 
the blood.  The chief damage is done by 
destroying the ojusi  due to complete 
opposite property.  Lastly all the doshas also 
gets involved along with Dhatus, 
particularly the rakta, the whole body 
systems get disturbed.  In the acute or 
chronic sequence of events initiated by 
innumerable unknown Visha dravyas, I 
propse that the visha etiology should be 
accepted for formation of granthi.  The 
dooshyodora  which has been proposed as 
NHL and other abdominal  metastasic 
disorders based on the present study has 
been very well supported by number of 
studies.  The word Granthi or tumour has 
been explained in both the gulmai and udara 
contexts by all Acharyas. 
 
NIIL is essentially the malignant tumour of 
the lymphoid system.  Although it presents 
with diverse range of diseases and sites, they 
have general similarities within the group as 
a whole.  The disease originates in the 
primary site of lymph nodes i.e. cervical, 
axillary, mediastinal, abdominal and 
inguinal  or in the extra nodal organs but 
very soon they spread and involve other 
lymphatic areas and spread to other organs.  
Lymphoma cells have tendency to infiltrate 
almost all tissues.  Involvement of bone 
marrow is quite common which results in 
leukemia. 
 
The  other primary solid tumours of the 
abdomen do not present like dooshyodara, 
but in advanced stages almost all of them 
progresses to dooshyodara.  Hence  in my 
study I considered another possibility as 
suggested by Sushruta  –  Abhayantara 
vidradhi.  Sushrutha  clearly differentiates 
the external and internal vidradhis.  Further 
he explains the difference between gulma 
and vidradhi in which the dhatu’s (tissue ?)  
involvement of vidradhi is made clear.   
Twelve difference sites of origin have been 
given and their  tendency to spread deeper 
into the dhatu’s  has been recognized.  The 
most striking point to be noted is (a) Internal 
vidradhi’si develop very fast (Brishatva), (b) 
freightening  (Ghora),  (c) deep rooted 
(Mahamoola), and (d) have typical tumours 
(gulma  roopa) with (e) anthill like growth 
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suggest malignant features found in the 
carcinomas and sarcomas of abdominal 
structures.  Considering the details attributed 
to vidradhi  and clinically observing various 
abdominal tumours I had very little doubt in 
accepting  abhyantara vidradi  as malignant 
tumour. 
 
TABLE 2. SIGNS AND SYMPTOMS AT THE TIME OF PRESENTATION AND IN 
UNCONTROLLED PROGRESSIVE DISEASE 
 
At the time of presentation  Uncontrolled disease 
Heaviness of the abdomen 
 
Distension of the abdomen 
 
Mass per abdomen 
 
Loss of appetite 
 
Indigestion 
 
Weakness and fatigue 
 
Dysponea 
 
Pallor 
 
Nausea & Vomiting 
 
Loss motions 
 
Loss of weight, excessive thirst 
 
Drowsy & sleepy, loss of tase 
 
Hepatomegaly, Splenomegaly 
 
Multiple nodes, Ascitis, Jaundice 
 
Fever 
 
Gross ascitis 
 
Oedema-pedal / general 
 
Deeply jaundiced 
 
Hepatic coma 
 
Unconsciousness 
 
Paraplegic 
 
Paralytic 
 
Malena 
 
Haematemesis 
 
Bleeding – other areas 
 
Breathlessness 
 
Severe cough 
 
My observations clearly suggests that all 
abdominal tumours have to be recognized 
either in gulma, udara or vidradhi.  There is 
no other diseases entity in the Ayurvedic 
literature relating to abdominal tumours.   
There is considerable amount of ambiguity 
and confusion and overlapping in the 
explanations.  For eg., all the tree entities are 
referred as granthis, but they are different.  
Internal vidradhi’s explanations are clearly 
like solid tumours but gulma  with only 
dosha involvement is a soft mobile mass.   Pages 218 - 231 
But gulma when chronic spreads all over the 
abdomen and gain the shape of turtle and 
becomes a killer.  Udara’s  by nature 
dreadful, non responsive and have granthi 
like masses.  All these can be associated 
with vishas, as mentioned by Sushuruta. 
 
The oncology experience and observation 
combining with Ayurvedic  experience and 
literature has led me to draw conclusions in 
the following way. 
 
All cancers in general and abdominal 
cancers studies here in particular have 
definite visha aetiology of dooshivisha type.  
The dosha lakshanas are not at all seen in 
most of the cancers till the disease is 
advanced suggests and supports this 
hypothesis and hence I wish to propose that 
vishass directly involve with the dhatus and 
pathogenesis is initiated.  Since majority of 
the population do not have shudda sharers 
(cleansed internal environment) the situation 
will be favourable, and granthii  will be 
formed.  The samprapthi of granthi, arbudai 
and  vidradhi  essentially involve rakta, 
mamsa and medas together which I feel can 
be due to specific dooshivishas.  The doshas 
automatically involved but do not show 
generalized symptoms as they are localized.  
Sushruta’s  six  kriyakalasi  certainly  cannot 
be appreciated in solid cancers because these 
tumours do not undergo these dosha based 
stages at all.  The gulma-granthi-vidradhi-
udara are closely associated conditions and 
whenever they are associated with visha 
aetiology perhaps the situation becomes 
malignant.  They can also be regarded as 
different stages which actually differ in 
different tumours. 
 
However histopathological classification, 
organ specific metastasis, detailed staging 
procedures, etc are not of much importance 
for the preliminary study and hence not 
discussed here.  More studies however 
should be done by team of Ayurvedic  
physicians for further discussions. 
 
ABDOMINAL TUMOURS (SPECIFIC) 
NO. (1) 
 
Apart from the tumours discussed above we 
find in the literature three specific conditions 
which are given separate status and relate to 
malignancies.  These are also abdominal 
tumours but specific to organs referred 
clearly viz. Yakritodara  –  Pleehodra.  
Raktagulma is not discussed here as I have 
not made studies on that.  These two 
conditions clinically referred as 
hepatomegaly and splenomagaly occurs in 
quite a number of begin and malignant 
conditions and  they are very important 
clinical signs, but in Ayurvedic literature the 
references are not only scarce but vague and 
confusing (pleehodra  is discussed 
separately).  The pleeha or spleen appears to 
be given more importance than liver.  The 
aetiology, pathogenesis and symptoms have 
been considered as common for both these 
organs. 
 
According to modern oncology and from my 
experience liver is an important organ of 
metastatic spread in number of cancers and 
signifies advance disease but spleen 
metastasis is seen only in haematological 
malignancies which is not considered as 
metastasis because spleen is a part of 
primary haematopoetic system.  In this study 
more than 400 cases were studied where 
liver involvement was documented 
clinically,  histological  and by imaging 
techniques.  The various types of cases 
studied are listed below. 
 
All patients presented with enlargement of 
liver and proved to be malignant were 
studied. 
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The following conditions are listed where 
hepatomegaly is associated. 
 
1.  Primarily liver malignance (Adults only) 
– Hepatocellular carcinoma. 
 
2.  Metastatic carcinomas with primary 
(Adults only) (a) breast (b) lung (c) 
stomach (d) oesophagus (e) pancreas. 
 
3.  Haematological malignancies (Adults 
and children) (a) lymphoma (b) 
Hodgkin’s disease (c) leukamias 
 
4.  Paediatric malignancies (a) Acute 
lymphoblastic leukemia (b) Non 
hodgkin’s disease (c) Hodgkin’s disease 
(d) Neuroblastoma (e) Hepatoblastoma. 
 
In the above mentioned conditions 
hepatomegaly is a definite conditions in 
some stage of the natural history of the 
disease.  Histopathologically confirmed 
cases were followed and examined at all 
stages.  The primary liver cancer patients 
have very uneventful vague history and 
seldom suffer from any serious problem 
except pain in the upper quadrant of the 
abdomen, but clinical exam reveals grossly 
enlarged liver, which is non tender and hard.  
Most of the patients present with huge mass 
with mild abdomen paid.  Gradually they 
develop progressive loss of appetite and 
weight in addition aversion to food.  In my 
observation 65% of patients developed 
jaundice and eventually died.  However till 
they develop these two terminal events the 
quality of life was remarkably good.  In case 
of metastic liver, the primary will be known 
majority of the cases.  A few cases will have 
occult primary or a small tumour.   
Clinically, patients with metastic liver are 
more ill and even small size liver 
enlargement make significant difference in 
quality of life due to diffuse involvement 
and aggressive proliferation of tumour cells.  
Most of the cases develop jaundice and 
ascitis and die at a faster rate than primary 
carcinoma.  In these cases in addition to 
liver the lymphnod metastasis in the 
abdomen will be usually associated. 
 
TABLE 3. SYMPTOMS ASSOCIATED WITH PRIMARY CARCINOMA LIVER AT 
PRESENTATION 
 
Symptoms  Percentage of patients 
1.  Right upper quadrant pain 
2.  Abdominal fullness 
3.  General weakness 
4.  Weight loss 
5.  Loss of appetite & indigestion 
6.  Jaundice 
7.  Mass felt 
8.  Haematemesis 
9.  Nausea / vomiting 
10. Fever 
70 
50 
50 
40 
40 
40 
25 
20 
20 
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TABLE 4. CLINICAL SIGNS FOUND IN CARCINOMA LIVER PATIENTS AT THE 
TIME OF DIAGNOSIS 
 
Signs & Symptoms  Percentage of patients 
1.  Hepatomegaly 
2.  Ascitis 
3.  Jaundice 
4.  Pedal oedema 
5.  Abdominal venous distension 
6.  Malena 
7.  Lymphadenopathy 
8.  Distant metastasis 
9.  Associated diseases 
 
100 
60 
30 
40 
50 
65 
40 
10 
25 
 
 
The haematological diseases with 
hepatomegaly can be clearly distinguished 
from other solid tumours without any 
ambiquity and hence they are not discussed 
here.  Other paediatric tumours can however 
be taken along with solid tumours discussed 
above. 
 
In  Ayurvedic  literature we come across a 
few diseases associated with hepatomegaly 
which is mentioned as a separate entity in 
some contexts.  The Yakrutodara in the 
udara contect and kumbhaka – haleemaka in 
the pandukamala context and special 
reference as mahodara yakritpleehe in the 
garavisha context are considered here as 
they clinically correlate to many malignant 
conditions.  The visha aetiology of Ayurveda 
is well supported by the modern toxic and 
vital aetiology.  The primary liver cancer has 
been related to malnutrition, dietary 
carcinogens like nitrosamines and a toxins, 
parasitic infections and cirrhoea from 
number of causes including alcohol.  The 
hepatitis B virus has been conclusively 
proved to be associated.  On the basis of 
these evidences and Ayurvedic reference to 
gara and dooshivisha and udara begins well 
known terminal condition of chronic 
pathological conditions of different diseases, 
the yakritodara is to be considered as 
malignant condition, whether it is primary or 
metastatic (irrespective of other primaries).  
In the study it was very clearly seen that not 
only the liver metastatic cases are udara 
conditions but they will progress to jalodara 
or dooshyodara conditions.  The non   
malignant hepatomegaly like cirrhosis which 
may also progress to jalodara is to be 
regarded as yakrit dosha like pleehadosha or 
as yakritvriddi. 
 
The concept of common aetiology and 
pathology for both liver and spleen 
mentioned in samhitas cannot be justified, 
since none of the evidence support.  In pure 
lymphoid malignancies alone we can clearly 
appreciate the involvement of both liver and Pages 218 - 231 
spleen but unlike other cancers they are 
reversible, and do not correlate with udara 
rogas. 
 
The primary cancer of the liver or 
hepatocellular carcinoma and all carcinomas 
and sarcomas that metastasizes to the liver 
or recognizable as yakritodara mentioned in 
Ayurvedic literature. 
 
ABDOMINAL TUMOURS (SPECIFIC) 
NO.2 
 
The third category of mass abdomen clinical 
presentation that can be seen in Ayurvedic 
literature is “pleeha” related disorders.  The 
terms used to describe are (1) Pleehadosha 
(2) Pleeha vriddhi (3) Pleehodara. 
 
Splenomegaly is a important sign in quite a 
number of both begin and malignant 
conditions.  In this study only malignant 
diseases were taken.  The following are the 
chief malignant diseases associated with 
splenomegaly studied. 
 
1.  Acute Lymphocytic Leukeamia (ALL) 
(Adults & Children) 
2.  Non-Hodgkin’s  Lymphoma  (NHL)       
(Adults & Children) 
3.  Hodgkin’ Disease (HD)  (Adults & 
Children) 
4.  Chronic Myeloid Leukeamia (CML)   
(Adults & Children) 
5.  Chronic Lymphocytic Leukeamia (CLL) 
(Adults only) 
6.  Hairy Cell Leukeamia (HCL)  (Adults 
only) 
 
300 cases of ALL, 200 cases of NHL, 280 
cases of HD, 250 cases of CML, 8 cases of 
CLL and 5 cases of HCL were studied 
between 1986 and 1992.  ALL and NHL are 
very acute conditions with very short history 
and aggressive behaviour and do not have 
any correlation to the pleeha group 
disorders.  Pleehavriddhi is to be taken as a 
sign only.  This fact is conclusively 
understood.  Rest of the conditions are 
chronic in nature and splenomegaly is the 
chief presenting sign except the HD.  The 
HD is in fact excluded as it has significant 
lymphnode involvement and splenomegaly 
is in fact only pleehavriddhi.  The CML and 
HCL were the only two conditions left out 
since the CLL has not only low incidence 
but completely asymptomatic till the disease 
reaches terminal stage. 
 
The CML patients were found to be unique 
and had typical symptoms and clinical 
course and attracted keen attention.  75% of 
the patients had gross splenomegaly which 
was non tender and hard and clearly like the 
tortoise shell (Koormapristavat) (6). 
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TABLE 5 : SIGNS AND SYMPTOMS AT THE TIME OF PRESENTATION 
 
Signs & Symptoms  Percentage of patients 
1.  Fatigue 
2.  Anemia – mild 
3.  Heaviness of abdomen with pain 
4.  Fever – low grade 
5.  Loss of appetite 
6.  Mass abdomen 
7.  Splenomegaly 
>16       cms 
10 – 16  cms 
5 – 10    cms 
< 5        cms 
8.  Nausea – vomiting 
9.  Cough, Respiratory problem 
10. Others 
90 
85 
80 
75 
60 
50 
 
40 
20 
20 
10 
15 
10 
20 
 
CML is a clonal myclo proliferative disorder 
of a pluripotent stem cell of the bone 
marrow and all the blood elements are 
involved.  The media age is 50 years and 
undoubtedly a adult disese.  It can easily be 
diagnosed by peripheral blood examination 
showing abnormal increase of the total count 
with lot of immature cells.  Usually it has a 
chronic phase ranging several years and then 
accelerate suddenly and goes to blastic or 
acute phase which is the terminal event of 
the disease process. 
 
The pleehodara mentioned in all the three 
classics have very clear resemblance to the 
CML observed in this study.  The signs and 
symptoms given above shows almost all the 
cases had similar presentation.   Prognosis is 
definitely bad as envisaged in Ayurveda.  
However, by the presently available therapy, 
the chronic phase can be extended to a few 
years. 
 
Except CML, none of the other 
splenomegaly groups has any resemblance 
to pleehodara.  Since udara roga has been 
grouped under maharogasi and pleehodara 
specially recognized as 4
th  in the order of 
Krichrata and the literature description was 
very obviously observed in the group 
studied in CML, the Pleehodara    is to be 
taken  as Chronic Myeloid Leukemia.   
Further there is no other disease that can be 
considered in the cancer group. However, 
the begin diseases have not been taken into 
consideration as they are unlikely to be 
udara but only pleehadosha or pleeha vridhi 
in my opinion. 
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Systematically worked up malignant mass 
abdomen cases has been discussed in the 
Ayurvedic framework.  I have proposed the 
Ayurvedic  visha aetiology as having very 
strong malignant potential.  Since the vishas 
have independent components to initiate a 
unique pathological process which is known 
to get involved with doshas and dhatus later, 
all cancers in general and the diseases 
discussed here in particular are to be taken 
as  vishajanya granthi vikaras.  I have 
concluded that UDARA-GULMA-
VIDRADI are the abdominal tumours which 
are having what we today understand as 
“malignant” or cancerous potential.  Further 
I wish to conclude that the modern diagnosis 
in the name of CANCER can never be 
equated with any single disease entity 
mentioned in Ayurvedic literature.  Modern 
concepts itself clearly says cancer is not a 
single kind of disease.  ARBUDA which is 
generally taken for all cancers is incorrect in 
this context as evident from the study of the 
abdominal tumours presented here. 
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